Diabetes technology

Improved Effectiveness of Immediate Continuous Glucose Monitoring in Hypoglycemia-Prone People with Type 1 Diabetes Compared with Hypoglycemia-Focused Psychoeducation Following a Previous Structured Education: A Randomized Controlled Trial

Diabetes Technol TherPublished Randomised controlled trial

Primary result · Patients reporting SHEResult — go to the resultDecrease −39%

Authors' conclusion

Immediate start of CGM is more effective than a hypoglycemia-focused reeducation program in reducing SHE risk and attaining glycemic targets in individuals with problematic hypoglycemia and IAH despite previous education in insulin dose adjustment.

Study context

Population
T1D patients with problematic hypoglycemia despite previous structured education in insulin adjustment; mean age 53, 56% females
Participants
52 patients
Comparison
Stepped-care vs immediate continuous glucose monitoring (CGM)
Primary endpoint
Number of participants with self-reported severe hypoglycemic event (SHE)

Primary result

Patients reporting SHE · 6 months

Decrease

−39%

P < 0.05

As reported in the abstract

Secondary outcomes

IAH restored · 6 months

OutcomeStepped-careCGMDifference (percentage-points)P value
HbA1c · 6 monthsDecreased more with CGM−0.47P < 0.05
TBR (<54 mg/dL) · 6 months−2.4P < 0.05
Started CGM/isCGM in stepped-care93%— not stated in the abstract

— not stated in the abstract

Patients reporting severe hypoglycemic event (SHE) · 12 months

Still higher in the stepped-care group

Patient-reported outcomes (PROs)

No differences were found in PROs

Original publication

Improved Effectiveness of Immediate Continuous Glucose Monitoring in Hypoglycemia-Prone People with Type 1 Diabetes Compared with Hypoglycemia-Focused Psychoeducation Following a Previous Structured Education: A Randomized Controlled Trial. Diabetes Technol Ther. Published 23 November 2022. doi:10.1089/dia.2022.0232

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.